Search
Search Results
-
Lipoprotein(a): what clinicians need to know
611PDF: 1003HTML: 31 -
iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025 - Focus on prevention and treatment of cardiometabolic disease
2457PDF: 2966Supplementary: 357Appendix: 293 -
Sex-based differences in characteristics, management, and outcomes in heart failure with reduced ejection fraction
887PDF: 266Supplementary: 161Appendix: 122HTML: 76 -
Is the obesity paradox present in left ventricular assist device recipients? A BMI-based analysis
267PDF: 295Supplementary: 160HTML: 36 -
Sex differences in clinical characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction
867PDF: 232Supplementary: 168Appendix: 121HTML: 53 -
Coronary artery calcium scoring. What clinicians need to know
1472PDF: 425HTML: 173 -
Applicability of obesity clinical practice guidelines in low- and middle-income countries
1408PDF: 710Appendix: 257HTML: 36 -
SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials
1295pdf: 294Supplementary Material: 48HTML: 158 -
Epidemiology of peripartum cardiomyopathy in Africa
2493PDF: 545HTML: 127 -
-
The Global Implementation Guidelines Initiative: how to optimize cardio-renal-metabolic care worldwide
3749PDF: 646Appendix: 426HTML: 33 -
Dyslipidemia and stroke-related mortality in the United States: a nationwide analysis for 2010-2020
344PDF: 97Supplementary: 22HTML: 29 -
The impact of frailty on in-hospital outcomes in patients with HFrEF
366PDF: 137Supplementary: 35HTML: 16 -
Modulation of cardiac metabolism in heart failure
2457PDF: 1201HTML: 60 -
Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients
2126PDF: 576SUPPLEMENTARY MATERIAL: 321GRAPHICAL ABSTRACT: 281HTML: 44

